Prevention of Post-Hepatectomy Liver Failure in Cirrhotic Patients Undergoing Minimally Invasive Liver Surgery for HCC : Has the Round Ligament to Be Preserved?
Post-hepatectomy liver failure (PHLF) represents a major cause of morbidity and mortality after liver resection. The factors related to PHLF are represented not only by the volume and function of the future liver remnant but also by the severity of portal hypertension. The aim of this study was to assess whether the preservation of the round ligament (RL) may mitigate portal hypertension, thus decreasing the risk of PHLF and ascites in cirrhotic patients while undergoing minimally invasive liver surgery (MILS). All the cirrhotic patients who underwent MILS for HCC from 2016 to 2021 in two international tertiary referral centers were retrospectively analyzed, comparing cases with the RL preserved vs. those with the RL divided. Only patients with cirrhosis ≥ Child A6, portal hypertension, and ICG-R15 > 10% were included. Main postoperative outcomes were compared, and the risk factors for postoperative ascites (severe PHLF, grade B/C) were investigated through a logistic regression. After the application of the selection criteria, a total of 130 MILS patients were identified, with 86 patients with the RL preserved and 44 with the RL divided. The RL-preserved group showed lower incidences of severe PHLF (7.0% vs. 20.5%, p = 0.023) and ascites (5.8% vs. 18.2%, p = 0.026) in comparison with the RL-divided group. After uni/multivariate analysis, the risk factors related to postoperative ascites were RL division and platelets < 92 × 103/µL, calculated with ROC analysis. The preservation of the round ligament during MILS may mitigate portal hypertension, preventing PHLF and ascites in cirrhotic patients with borderline liver function.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Cancers - 16(2024), 2 vom: 15. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vivarelli, Marco [VerfasserIn] |
---|
Links: |
---|
Themen: |
Ascites |
---|
Anmerkungen: |
Date Revised 28.01.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/cancers16020364 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36745338X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36745338X | ||
003 | DE-627 | ||
005 | 20240128232015.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240123s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/cancers16020364 |2 doi | |
028 | 5 | 2 | |a pubmed24n1273.xml |
035 | |a (DE-627)NLM36745338X | ||
035 | |a (NLM)38254855 | ||
035 | |a (PII)364 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vivarelli, Marco |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevention of Post-Hepatectomy Liver Failure in Cirrhotic Patients Undergoing Minimally Invasive Liver Surgery for HCC |b Has the Round Ligament to Be Preserved? |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.01.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Post-hepatectomy liver failure (PHLF) represents a major cause of morbidity and mortality after liver resection. The factors related to PHLF are represented not only by the volume and function of the future liver remnant but also by the severity of portal hypertension. The aim of this study was to assess whether the preservation of the round ligament (RL) may mitigate portal hypertension, thus decreasing the risk of PHLF and ascites in cirrhotic patients while undergoing minimally invasive liver surgery (MILS). All the cirrhotic patients who underwent MILS for HCC from 2016 to 2021 in two international tertiary referral centers were retrospectively analyzed, comparing cases with the RL preserved vs. those with the RL divided. Only patients with cirrhosis ≥ Child A6, portal hypertension, and ICG-R15 > 10% were included. Main postoperative outcomes were compared, and the risk factors for postoperative ascites (severe PHLF, grade B/C) were investigated through a logistic regression. After the application of the selection criteria, a total of 130 MILS patients were identified, with 86 patients with the RL preserved and 44 with the RL divided. The RL-preserved group showed lower incidences of severe PHLF (7.0% vs. 20.5%, p = 0.023) and ascites (5.8% vs. 18.2%, p = 0.026) in comparison with the RL-divided group. After uni/multivariate analysis, the risk factors related to postoperative ascites were RL division and platelets < 92 × 103/µL, calculated with ROC analysis. The preservation of the round ligament during MILS may mitigate portal hypertension, preventing PHLF and ascites in cirrhotic patients with borderline liver function | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HCC | |
650 | 4 | |a ascites | |
650 | 4 | |a minimally invasive liver surgery | |
650 | 4 | |a oncologic surgery | |
650 | 4 | |a portal hypertension | |
650 | 4 | |a post-hepatectomy liver failure | |
650 | 4 | |a round ligament | |
700 | 1 | |a Mocchegiani, Federico |e verfasserin |4 aut | |
700 | 1 | |a Wakabayashi, Taiga |e verfasserin |4 aut | |
700 | 1 | |a Gaudenzi, Federico |e verfasserin |4 aut | |
700 | 1 | |a Nicolini, Daniele |e verfasserin |4 aut | |
700 | 1 | |a Al-Omari, Malek A |e verfasserin |4 aut | |
700 | 1 | |a Conte, Grazia |e verfasserin |4 aut | |
700 | 1 | |a Borgheresi, Alessandra |e verfasserin |4 aut | |
700 | 1 | |a Agostini, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Rossi, Roberta |e verfasserin |4 aut | |
700 | 1 | |a Fujiyama, Yoshiki |e verfasserin |4 aut | |
700 | 1 | |a Giovagnoni, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Wakabayashi, Go |e verfasserin |4 aut | |
700 | 1 | |a Benedetti Cacciaguerra, Andrea |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancers |d 2009 |g 16(2024), 2 vom: 15. Jan. |w (DE-627)NLM198667213 |x 2072-6694 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2024 |g number:2 |g day:15 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/cancers16020364 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2024 |e 2 |b 15 |c 01 |